Evidence map›Paper›PMID 30537007›Full record

ReviewBioEssays : news and reviews in molecular, cellular and developmental biology2019

HIV Disease Progression: Overexpression of the Ectoenzyme CD38 as a Contributory Factor?

Juan C Rodríguez-Alba, Amayrani Abrego-Peredo, Carlos Gallardo-Hernández, Jocelyn Pérez-Lara, Wendolaine Santiago-Cruz, Wei Jiang, Enrique Espinosa

Open access · greenAbstract readReview
In one paragraph

Review in BioEssays : news and reviews in molecular, cellular and developmental biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. NADThe Journal of general virology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. The role of CD38 in HIV infection.AIDS research and therapy · 2021
    Review
  14. NADFrontiers in molecular biosciences · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Juan C Rodríguez-AlbaFlow Cytometry Core Facility, Instituto de Ciencias de la Salud, Universidad Veracruzana, Av. Luis, Dr. Castelazo Ayala s/n, 91190 Xalapa, Veracruz, Mexico.
Amayrani Abrego-PeredoDoctorado en Ciencias de la Salud, Instituto de Ciencias de la Salud, Universidad Veracruzana, Av. Luis, Dr. Castelazo Ayala s/n, 91190 Xalapa, Veracruz, Mexico.
Carlos Gallardo-HernándezDoctorado en Ciencias de la Salud, Instituto de Ciencias de la Salud, Universidad Veracruzana, Av. Luis, Dr. Castelazo Ayala s/n, 91190 Xalapa, Veracruz, Mexico.
Jocelyn Pérez-LaraDoctorado en Ciencias de la Salud, Instituto de Ciencias de la Salud, Universidad Veracruzana, Av. Luis, Dr. Castelazo Ayala s/n, 91190 Xalapa, Veracruz, Mexico.
Wendolaine Santiago-CruzMaestría en Ciencias de la Salud, Instituto de Ciencias de la Salud, Universidad Veracruzana, Av. Luis, Dr. Castelazo Ayala s/n, 91190 Xalapa, Veracruz, Mexico.
Wei JiangDepartment of Microbiology and Immunology, Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 803, MSC 623, Charleston, SC 29425, USA.
Enrique EspinosaLaboratory of Integrative Immunology, National Institute of Respiratory Diseases (INER), Calzada de Tlalpan 4502, 14080 Mexico City, Mexico.ORCID 0000-0002-3231-1626
Universidad Veracruzana · MXMedical University of South Carolina · US

Funding

Synergistic effect of HIV virions and bacterial LPS on memory B cell apoptosisR01AI091526 · NIAID · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JIANG, WEI · 2011 to 2015
$1.4M
On the pathogenic role of anti-CD4 antibody in poor CD4+ T cell recovery after antiretroviral therapy in HIV diseaseR01AI128864 · NIAID · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JIANG, WEI · 2017 to 2021
$1.1M
NIAID NIH HHS R01 AI091526NIAID NIH HHS R01 AI128864NIH HHS AI091526NIH HHS AI128864
6 · The paper itself

Abstract

Despite abundant evidence associating CD38 overexpression and CD4 T cell depletion in HIV infection, no causal relation has been investigated. To address this issue, a series of mechanisms are proposed, supported by evidence from different fields, by which CD38 overexpression can facilitate CD4 T cell depletion in HIV infection. According to this model, increased catalytic activity of CD38 may reduce CD4 T cells' cytoplasmic nicotin-amide adenine dinucleotide (NAD), leading to a chronic Warburg effect. This will reduce mitochondrial function. Simultaneously, CD38's catalytic products ADPR and cADPR may be transported to the cytoplasm, where they can activate calcium channels and increase cytoplasmic Ca

Indexed as

Gene Expression RegulationADP-ribosyl Cyclase 1Disease ProgressionHIV InfectionsHumansMembrane GlycoproteinsUp-RegulationADP-ribosyl Cyclase 1CD38 protein, humanMembrane GlycoproteinsCD38CD4-Positive T lymphocytesHIV/AIDSimmune activationimmunometabolismNADWarburg effect

Identifiers

PMID30537007
PMCPMC6545924
OpenAlexW2905136524

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.